Biotech Values

[dangerM]

RVNC AGN ... BB article on Botox competitor

This seems to be mainly about Daewoong Pharmaceutical Co. and the pie chart does not drill down into cosmetic vs. medical use. Still, I had not known about Daewoong.

https://www.bloomberg.com/news/articles/2017-11-30/hedge-fund-manager-who-backed-allergan-bets-on-botox-alternative

...Daewoong is already locking horns with Medy-Tox Inc., which has a licensing agreement with Allergan, .... Medy-Tox, whose Botox rival hit Korean shelves in 2006 but isn’t available in the U.S., alleges Nabota was developed with stolen technology, a claim Daewoong denies. ...